High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$654K
$654,871
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LENZ
P
LENZ Therapeutics, Inc.
Chevallard Daniel R.
• CFO
Discretionary BuyΔOwn +139.2%
2026-03-27
$64,275
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
CFO
Discretionary BuyΔOwn +139.2%
|
2026-03-27 | $64,275 | P | Form 4 |
| LENZ |
LENZ Therapeutics, Inc.
|
Director
Discretionary Buy
|
2026-03-27 | $49,890 | P | Form 4 |
|
LENZ
P
LENZ Therapeutics, Inc.
Schimmelpennink Evert B.
• CEO
Discretionary BuyΔOwn +57.1%
2026-03-27
$251,411
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
CEO
Discretionary BuyΔOwn +57.1%
|
2026-03-27 | $251,411 | P | Form 4 |
|
LENZ
P
LENZ Therapeutics, Inc.
Chevallard Daniel R.
• CFO
Discretionary BuyΔOwn +67.9%
2025-11-07
$50,017x2
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
CFO
Discretionary BuyΔOwn +67.9%
|
2025-11-07 | $50,017x2 | P | Form 4 |
| LENZ |
LENZ Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-11-07 | $239,278 | P | Form 4 |